A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees: B. The Masterplan for the Pharmaceutical Sector of Tanzania Mainland 1992 - 2000: 4. Pharmacy Board: 4.2. Drug Legislation

Home page | Help | Clear

English | French

Search | Categories | Titles A-Z | Countries | Compare countries | Index

Expand Document

Printable HTML version

Export document as HTML file Help


	A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees (WHO; 1993; 42 pages)
		Foreword
		A. The Tanzania National Drug Policy
			1. Background
			2. Initial Activities
			3. Tanzania National Drug Policy 1991
				I. Introduction*
				II. Drug Availability
					1. Drug selection
					2. Drug procurement
					3. Distribution
					4. Quality assurance
				III. Rational Drug Use
					1. Education and Training
					2. Drug Information
					3. Control of Misuse
					4. Hospital Pharmaceuticals and Supplies Committees
					5. Advertising and Promotion
				IV. National Pharmaceutical Production
					1. Promotion
					2. Product Range and Coordination
					3. Pricing mechanisms
				V. Traditional Medicine
					1. Promotion
					2. Research and Production
					3. Safety and Use
				VI. Intersectoral Cooperation
				VII. Technical Cooperation with Other Countries
				VIII. Financial Resources
				IX. Legislation
			4. Notes of clarification on some statements in the National Drug Policy document
		B. The Masterplan for the Pharmaceutical Sector of Tanzania Mainland 1992 - 2000
			1. Introduction
			2. Central Medical Stores (CMS)
			3. Pharmaceuticals and Supplies Unit (PSU)
			4. Pharmacy Board
				4.1. General
				4.2. Drug Legislation
				4.3. Drug Registration
				4.4. Drug Inspection
				4.5. Drug Information
				4.6. Drug Advertising and Promotion
			5. Drug Quality Assurance and Control
			6. Local Production of Pharmaceutical Products
			7. Traditional Medicine
			8. Local Financing of Drugs
			9. Conclusions
		C. Hospital Therapeutic Committees
			I. Introduction
			II. Establishing Therapeutic Committees
			III. Functions of Hospital Therapeutic Committees
			IV. Discussion of the Functions
			V. Composition of Hospital Therapeutic Committees
			VI. Support of Hospital Therapeutic Committees

4.2. Drug Legislation

The present Pharmaceuticals and Poisons Act (1978) is outdated. It is partly a reflection of the pre-second world war legislation in the UK and it is not providing an adequate legal basis to support and enforce implementation of the National Drug Policy. It will therefore be replaced by a new modern Act. This Act will consider fundamental essential requirements as well as constraints in their implementation, caused by the prevailing conditions in the Tanzanian Health Sector.

The Act will give an appropriate framework within which the Pharmacy Board can operate effectively. The Board should thus become a properly functioning drug regulatory authority, which ensures that all pharmaceutical products conform to acceptable standards of quality, safety and efficacy and that all premises and machines for manufacturing, storing and distributing these products comply with requirements, so that drugs reaching the patients are safe and effective.

Three main activities will fall under the direct authority of the Board:

- Drug Registration
- Drug Inspection
- Drug Information.

Please provide your feedback

English | French